| Year |
Citation |
Score |
| 2023 |
Chi K, Luo Z, Zhao H, Li Y, Liang Y, Xiao Z, He Y, Zhang H, Ma Z, Zeng L, Zhou R, Feng M, Li W, Rao H, Yi M. The impact of tumor characteristics on cardiovascular disease death in breast cancer patients with CT or RT: a population-based study. Frontiers in Cardiovascular Medicine. 10: 1149633. PMID 37229229 DOI: 10.3389/fcvm.2023.1149633 |
0.385 |
|
| 2022 |
Murphy BL, Yi M, Barrera AG, Tripathy D, Hunt KK, Arun BK. ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Annals of Surgical Oncology. PMID 36210399 DOI: 10.1245/s10434-022-12519-8 |
0.405 |
|
| 2022 |
Murphy BL, Yi M, Gutierrez Barrera AM, Tripathy D, Hunt KK, Arun BK. Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Annals of Surgical Oncology. PMID 36094691 DOI: 10.1245/s10434-022-12468-2 |
0.435 |
|
| 2021 |
DeSnyder SM, Yi M, Boccardo F, Feldman S, Klimberg VS, Smith M, Thiruchelvam PTR, McLaughlin S. ASO Visual Abstract: American Society of Breast Surgeons Practice Patterns for Patients At-risk and Affected by Breast Cancer-Related Lymphedema. Annals of Surgical Oncology. PMID 34628576 DOI: 10.1245/s10434-021-10608-8 |
0.412 |
|
| 2021 |
DeSnyder SM, Yi M, Boccardo F, Feldman S, Klimberg VS, Smith M, Thiruchelvam PTR, McLaughlin S. American Society of Breast Surgeons' Practice Patterns for Patients at Risk and Affected by Breast Cancer-Related Lymphedema. Annals of Surgical Oncology. PMID 34333706 DOI: 10.1245/s10434-021-10494-0 |
0.433 |
|
| 2021 |
Kilgore LJ, Yi M, Bevers T, Coyne R, Lazzaro M, Lane D, Albarracin C, Bedrosian I. Risk of Breast Cancer in Selected Women with Atypical Ductal Hyperplasia Who do not Undergo Surgical Excision. Annals of Surgery. PMID 33914469 DOI: 10.1097/SLA.0000000000004849 |
0.383 |
|
| 2020 |
Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian I. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing. Annals of Surgical Oncology. PMID 32720048 DOI: 10.1245/S10434-020-08889-6 |
0.485 |
|
| 2020 |
Kilgore LJ, Yi M, Bevers TB, Coyne R, Lazzaro M, Lane DL, Albarracin CT, Bedrosian I. Breast cancer events in women with atypical ductal hyperplasia who do not undergo surgical excision. Journal of Clinical Oncology. 38: 1562-1562. DOI: 10.1200/Jco.2020.38.15_Suppl.1562 |
0.549 |
|
| 2020 |
Ewane E, Yi M, Akhtar A, Brewster AM, McNeil-Haughton L, Hunt KK, Black DM. Abstract C039: Differences in breast cancer survival by race, age, and tumor estrogen receptor status Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C039 |
0.481 |
|
| 2020 |
Clifton KK, Raghavendra AS, Yi M, Litton J, Tripathy D, Karuturi M. Abstract P5-11-03: Practice patterns and outcomes of post progression treatment after CDK 4/6 inhibitors Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-11-03 |
0.412 |
|
| 2020 |
Yi M, Smith B, Gregor MCM, Caudle A, DeSnyder S, Kuerer H, Hunt K. Comparing Survival Differences Between Breast-Conserving Therapy and Mastectomy in Patients with Early-Stage Breast Cancer International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.524 |
0.561 |
|
| 2019 |
Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Annals of Surgical Oncology. PMID 31820211 DOI: 10.1245/S10434-019-08091-3 |
0.346 |
|
| 2019 |
Li S, Yang J, Shen Y, Zhao X, Zhang L, Wang B, Li P, Wang Y, Yi M, Yang J. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database. Bmc Public Health. 19: 1592. PMID 31783815 DOI: 10.1186/S12889-019-7947-Y |
0.497 |
|
| 2019 |
Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EA. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors. Annals of Surgical Oncology. PMID 31667721 DOI: 10.1245/S10434-019-07983-8 |
0.547 |
|
| 2019 |
Zhang X, Zhao H, Zhang Y, Yang X, Zhang J, Yi M, Zhang C. The microRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes. The Journal of Surgical Research. PMID 31635836 DOI: 10.1016/j.jss.2019.09.018 |
0.304 |
|
| 2019 |
Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK. Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgery. PMID 31436549 DOI: 10.1097/Sla.0000000000003551 |
0.526 |
|
| 2019 |
Qiu R, Zhao W, Yang J, Shen Y, Wang B, Li P, Zhao A, Tian Q, Zhang M, Yi M, Yang J, Dong D. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database. Journal of Breast Cancer. 22: 297-310. PMID 31281731 DOI: 10.4048/Jbc.2019.22.E18 |
0.551 |
|
| 2019 |
Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JP, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, et al. Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30867218 DOI: 10.1158/1078-0432.Ccr-18-3274 |
0.456 |
|
| 2019 |
Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM. Surgeon perception versus reality: Opioid use after breast cancer surgery. Journal of Surgical Oncology. PMID 30737785 DOI: 10.1002/Jso.25395 |
0.382 |
|
| 2019 |
Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Yang J, Yi M, Carey JP, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, et al. Abstract 323: Combined inhibition of STAT-3 & DNA repair in palbociclib resistant breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-323 |
0.436 |
|
| 2018 |
Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JP, Bui T, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, et al. Cyclin E overexpression sensitizes triple negative breast cancer to Wee1 kinase Inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30181387 DOI: 10.1158/1078-0432.Ccr-18-1446 |
0.435 |
|
| 2018 |
King L, Yi M, Krishnamurthy S, Hunt K, Thompson A. Abstract P4-15-10: Second breast events after DCIS: Where, what and when? Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-15-10 |
0.434 |
|
| 2018 |
Clifton K, Kimmel J, Yi M, Chad B, Litton J, Debu T, Meghan K. Abstract P3-11-03: The impact of dose delays and reductions on toxicity and progression free survival (PFS) in patients receiving palbociclib Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-11-03 |
0.301 |
|
| 2018 |
Karuturi M, Katherine C, Kimmel J, Yi M. The impact of dose delays and reductions on progression free survival (PFS) in older patients with metastatic breast cancer receiving palbocilib European Journal of Cancer. 92: S111. DOI: 10.1016/s0959-8049(18)30557-4 |
0.423 |
|
| 2017 |
Zhu XF, Yi M, He J, Tang W, Lu MY, Li T, Feng ZB. Pathological significance of MAD2L1 in breast cancer: an immunohistochemical study and meta analysis. International Journal of Clinical and Experimental Pathology. 10: 9190-9201. PMID 31966791 |
0.362 |
|
| 2017 |
Wu Y, Liu H, Du XL, Wang F, Zhang J, Cui X, Li E, Yang J, Yi M, Zhang Y. Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II-IV rectal cancer. Oncotarget. 8: 106913-106925. PMID 29290999 DOI: 10.18632/Oncotarget.22460 |
0.447 |
|
| 2017 |
Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA. Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer. Jama Oncology. PMID 29222540 DOI: 10.1001/Jamaoncol.2017.4298 |
0.504 |
|
| 2017 |
Yang J, Du XL, Li S, Wu Y, Lv M, Dong D, Zhang L, Chen Z, Wang B, Wang F, Shen Y, Li E, Yi M, Yang J. The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012. Bmc Cancer. 17: 783. PMID 29166866 DOI: 10.1186/S12885-017-3765-8 |
0.369 |
|
| 2017 |
Li S, Wang X, Yang J, Lv M, Zhang X, Li C, Zhang L, Shen Y, Zhang X, Chen Z, Wang F, Wang X, Li D, Yi M, Yang J. Clinicopathological features and survival of early stage breast cancer in northwest China: A population-based retrospective study of 1287 patients. Thoracic Cancer. PMID 28976077 DOI: 10.1111/1759-7714.12503 |
0.504 |
|
| 2017 |
Chen Z, Yang J, Li S, Lv M, Shen Y, Wang B, Li P, Yi M, Zhao X, Zhang L, Wang L, Yang J. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma. Plos One. 12: e0182397. PMID 28863134 DOI: 10.1371/Journal.Pone.0182397 |
0.43 |
|
| 2017 |
Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KK. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. Annals of Surgical Oncology. PMID 28726077 DOI: 10.1245/S10434-017-6009-X |
0.545 |
|
| 2017 |
Vijayaraghavan S, Karakas C, Doostan I, Chen X, Bui T, Yi M, Raghavendra AS, Zhao Y, Bashour SI, Ibrahim NK, Karuturi M, Wang J, Winkler JD, Amaravadi RK, Hunt KK, et al. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers. Nature Communications. 8: 15916. PMID 28653662 DOI: 10.1038/Ncomms15916 |
0.498 |
|
| 2017 |
Wang B, Yang J, Li S, Lv M, Chen Z, Li E, Yi M, Yang J. Tumor location as a novel high risk parameter for stage II colorectal cancers. Plos One. 12: e0179910. PMID 28644878 DOI: 10.1371/Journal.Pone.0179910 |
0.45 |
|
| 2017 |
Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RF. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. The Breast Journal. PMID 28608612 DOI: 10.1111/Tbj.12829 |
0.551 |
|
| 2017 |
Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu P, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget. PMID 28410201 DOI: 10.18632/Oncotarget.16694 |
0.35 |
|
| 2017 |
Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. PMID 28107181 DOI: 10.18632/Oncotarget.14689 |
0.462 |
|
| 2017 |
Weiss A, Chavez-Mac Gregor M, Lichtensztajn D, Yi M, Clarke CA, Giordano SH, Hunt K, Mittendorf EA. Validation of the AJCC 8th edition prognostic stage in breast cancer. Journal of Clinical Oncology. 35: e23186-e23186. DOI: 10.1200/Jco.2017.35.15_Suppl.E23186 |
0.422 |
|
| 2017 |
Mittendorf E, Vila J, Yi M, Chavez-MacGregor M, Chen R, Giordano S, Hunt K. Abstract P6-09-17: Evaluation of a risk score based on biologic factors to enhance prognostic stratification by the American Joint Committee on Cancer (AJCC) Staging System Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P6-09-17 |
0.492 |
|
| 2017 |
Vijayaraghavan S, Karakas C, Chen X, Doostan I, Raghavendra AS, Yi M, Amaravadi R, Hunt K, Tripathy D, Keyomarsi K. Abstract 2338: CDK4/6 and autophagy inhibitors synergize to induce senescence in cancers with an intact G1/S checkpoint Cancer Research. 77: 2338-2338. DOI: 10.1158/1538-7445.Am2017-2338 |
0.489 |
|
| 2017 |
Tadros AB, Lin H, MacGregor MC, Bedrosian I, Shen Y, Yi M, Giordano S, Hunt KK, Mittendorf EA. Validation of a Risk Score to Enhance Prognostic Stratification of Breast Cancer Patients Using the National Cancer Data Base (NCDB) Journal of the American College of Surgeons. 225: S26. DOI: 10.1016/J.Jamcollsurg.2017.07.036 |
0.528 |
|
| 2016 |
Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D, Wang F, Li EX, Yi M, Yang J. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. Plos One. 11: e0167540. PMID 27936129 DOI: 10.1371/Journal.Pone.0167540 |
0.397 |
|
| 2016 |
Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin A, Adjapong O, Hortobogyi GN, Bondy ML, Thompson PA, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, et al. Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27881578 DOI: 10.1158/1078-0432.Ccr-16-2217 |
0.505 |
|
| 2016 |
FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Annals of Surgical Oncology. PMID 27822630 DOI: 10.1200/Jco.2013.31.26_Suppl.53 |
0.533 |
|
| 2016 |
Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, et al. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Annals of Surgical Oncology. PMID 27406093 DOI: 10.1245/S10434-016-5407-9 |
0.519 |
|
| 2016 |
Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. Plos One. 11: e0156617. PMID 27244238 DOI: 10.1371/Journal.Pone.0156617 |
0.376 |
|
| 2016 |
Yi M, Hunt KK. Organizing a breast cancer database: data management. Chinese Clinical Oncology. PMID 27197511 DOI: 10.21037/Cco.2016.04.04 |
0.371 |
|
| 2016 |
Karakas C, Biernacka A, Bui T, Sahin A, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi K. Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer. The American Journal of Pathology. PMID 27182644 DOI: 10.1016/J.Ajpath.2016.02.024 |
0.4 |
|
| 2015 |
Yi M, Hunt KK. Optimizing Mammography Screening Intervals. Jama. 314: 1635-6. PMID 26501538 DOI: 10.1001/Jama.2015.13149 |
0.448 |
|
| 2015 |
Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Research : Bcr. 17: 87. PMID 26108797 DOI: 10.1186/S13058-015-0572-5 |
0.46 |
|
| 2015 |
Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Annals of Surgical Oncology. PMID 25905585 DOI: 10.1245/S10434-015-4547-7 |
0.361 |
|
| 2015 |
Luo S, Su X, Yi M, Hunt KK. Simultaneous inference of a misclassified outcome and competing risks failure time data. Journal of Applied Statistics. 42: 1080-1090. PMID 25821331 DOI: 10.1080/02664763.2014.995606 |
0.667 |
|
| 2015 |
Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KK. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1119-27. PMID 25488970 DOI: 10.1200/Jco.2014.57.2958 |
0.511 |
|
| 2015 |
Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Annals of Surgical Oncology. 22: 90-5. PMID 25249256 DOI: 10.1245/S10434-014-3991-0 |
0.556 |
|
| 2015 |
Karakas C, Francis A, Yi M, Sahin A, Keyomarsi K, Hunt K. Abstract 3772: Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer Cancer Research. 75: 3772-3772. DOI: 10.1158/1538-7445.Am2015-3772 |
0.479 |
|
| 2014 |
Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Research : Bcr. 16: 3417. PMID 25551582 DOI: 10.1186/S13058-014-0497-4 |
0.503 |
|
| 2014 |
Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. Plos One. 9: e110281. PMID 25333877 DOI: 10.1371/Journal.Pone.0110281 |
0.489 |
|
| 2014 |
Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study. American Journal of Clinical Oncology. PMID 25068470 DOI: 10.1097/Coc.0000000000000104 |
0.374 |
|
| 2014 |
Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Annals of Surgical Oncology. 21: 3440-7. PMID 24859939 DOI: 10.1245/S10434-014-3813-4 |
0.53 |
|
| 2014 |
Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. Plos One. 9: e89778. PMID 24587029 DOI: 10.1371/Journal.Pone.0089778 |
0.466 |
|
| 2014 |
Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Which threshold for ER positivity? a retrospective study based on 9639 patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1004-11. PMID 24562447 DOI: 10.1093/Annonc/Mdu053 |
0.403 |
|
| 2014 |
Luo S, Su X, DeSantis SM, Huang X, Yi M, Hunt KK. Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event. Statistics in Medicine. 33: 2554-66. PMID 24473943 DOI: 10.1002/Sim.6101 |
0.687 |
|
| 2014 |
Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Annals of Surgical Oncology. 21: 60-5. PMID 24046126 DOI: 10.1245/S10434-013-3276-Z |
0.525 |
|
| 2013 |
Kuerer HM, Bassett RL, Mittendorf EA, Yi M, Hunt K, Babiera G, Caudle AS, Black DM, Bedrosian I, Meric-Bernstam F, Hwang RF. Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 53. PMID 28136670 DOI: 10.1200/jco.2013.31.26_suppl.53 |
0.446 |
|
| 2013 |
Duong MT, Akli S, Macalou S, Biernacka A, Debeb BG, Yi M, Hunt KK, Keyomarsi K. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer Research. 73: 5556-68. PMID 23955388 DOI: 10.1158/0008-5472.Can-13-0013 |
0.382 |
|
| 2013 |
Liu P, Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British Journal of Cancer. 109: 1302-9. PMID 23907433 DOI: 10.1038/Bjc.2013.387 |
0.442 |
|
| 2013 |
Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. British Journal of Cancer. 108: 1508-14. PMID 23470470 DOI: 10.1038/Bjc.2013.97 |
0.361 |
|
| 2013 |
Park YJ, Kim MJ, Kim HR, Yi MS, Chung KH, Oh SM. Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells. Archives of Pharmacal Research. 36: 102-8. PMID 23335025 DOI: 10.1007/s12272-013-0002-0 |
0.416 |
|
| 2013 |
Hunt KK, Wingate H, Yokota T, Liu Y, Mills GB, Zhang F, Fang B, Su CH, Zhang M, Yi M, Keyomarsi K. Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Research : Bcr. 15: R3. PMID 23320734 DOI: 10.1186/Bcr3374 |
0.531 |
|
| 2013 |
Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Annals of Surgery. 257: 173-9. PMID 23291658 DOI: 10.1097/Sla.0B013E3182805C4A |
0.512 |
|
| 2013 |
Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KK. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Annals of Surgical Oncology. 20: 1514-21. PMID 23224829 DOI: 10.1245/S10434-012-2774-8 |
0.565 |
|
| 2013 |
Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Annals of Surgical Oncology. 20: 1267-74. PMID 23224828 DOI: 10.1245/S10434-012-2755-Y |
0.501 |
|
| 2013 |
Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. Journal of the American College of Surgeons. 216: 105-13. PMID 23122536 DOI: 10.1016/J.Jamcollsurg.2012.09.005 |
0.424 |
|
| 2013 |
Luo S, Yi M, Huang X, Hunt KK. A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer. Statistics in Medicine. 32: 2320-34. PMID 22996169 DOI: 10.1002/Sim.5629 |
0.674 |
|
| 2013 |
Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle AS, Hunt K, Wu Y. Applicability of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial results in invasive lobular carcinoma. Journal of Clinical Oncology. 31: 1103-1103. DOI: 10.1200/Jco.2013.31.15_Suppl.1103 |
0.485 |
|
| 2012 |
Gadgil PV, Bassett R, Hunt K, Mittendorf EA, Yi M, Babiera G, Kuerer HM, Ross MI, Bedrosian I, Meric-Bernstam F, Hwang RF. Nomogram to predict sentinel lymph node involvement in patients with clinically node-negative breast cancer receiving neoadjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 150. PMID 28146761 DOI: 10.1200/Jco.2012.30.27_Suppl.150 |
0.498 |
|
| 2012 |
Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Annals of Surgical Oncology. 19: 3177-84. PMID 22772869 DOI: 10.1245/S10434-012-2484-2 |
0.429 |
|
| 2012 |
Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. 118: 6287-96. PMID 22648744 DOI: 10.1002/Cncr.27564 |
0.523 |
|
| 2012 |
Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi K. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients. Plos Genetics. 8: e1002538. PMID 22479189 DOI: 10.1371/Journal.Pgen.1002538 |
0.401 |
|
| 2012 |
Yi M, Liu P, Li X, Mittendorf EA, He J, Ren Y, Nayeemuddin K, Hunt KK. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. 118: 4117-25. PMID 22460701 DOI: 10.1002/Cncr.27399 |
0.49 |
|
| 2012 |
Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 600-7. PMID 22253459 DOI: 10.1200/Jco.2011.36.4976 |
0.661 |
|
| 2012 |
Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Annals of Surgery. 255: 109-15. PMID 22167004 DOI: 10.1097/Sla.0B013E318238F461 |
0.4 |
|
| 2012 |
Kelley BP, Valero V, Yi M, Kronowitz SJ. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plastic and Reconstructive Surgery. 129: 305-14. PMID 21987043 DOI: 10.1097/Prs.0B013E31823Ae86C |
0.405 |
|
| 2012 |
Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Reply to K.J. Van Zee et al Journal of Clinical Oncology. 30: 3144-3145. DOI: 10.1200/Jco.2012.43.9406 |
0.429 |
|
| 2012 |
Dallas NA, Yi M, Hunt K, Shah RR, Kuerer HM, Litton JK, Wu Y, Caudle AS, Meric-Bernstam F, Sahin AA, Mittendorf EA. Evaluation of the stage IB designation of the 7th edition of the AJCC Staging System. Journal of Clinical Oncology. 30: 1130-1130. DOI: 10.1200/Jco.2012.30.15_Suppl.1130 |
0.4 |
|
| 2012 |
Yi M, Mittendorf EA, Hwang RF, Babiera G, Kuerer HM, Crow J, Lange G, Shah RR, Hunt K. Are mastectomy rates really increasing? Experiences from a single institution and a population-based database. Journal of Clinical Oncology. 30: 1028-1028. DOI: 10.1200/Jco.2012.30.15_Suppl.1028 |
0.514 |
|
| 2012 |
Yi M, Huo L, Koenig K, Mittendorf E, Meric-Bernstam F, Kuerer H, Bedrosian I, Symmans W, Hortobagyi G, Crow J, Shah R, Hunt K. Abstract P1-07-09: Estrogen receptor positivity: 10% or 1%? Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-07-09 |
0.433 |
|
| 2011 |
Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera G, Yi M, Ross MI, Hortobagyi GN, Hunt K. Impact of chemotherapy timing on local-regional failures in patients with breast cancer undergoing breast-conserving therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 82. PMID 27958071 DOI: 10.1200/Jco.2011.29.27_Suppl.82 |
0.485 |
|
| 2011 |
Yi M, Mittendorf EA, Buchholz TA, Sahin AA, Kuerer HM, Luo S, Bilimoria KY, Crow J, Cormier JN, Gonzalez-Angulo AM, Buzdar A, Hortobagyi GN, Hunt K. A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 92. PMID 27957920 DOI: 10.1200/Jco.2011.29.27_Suppl.92 |
0.665 |
|
| 2011 |
Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4654-61. PMID 22084362 DOI: 10.1200/Jco.2011.38.3174 |
0.656 |
|
| 2011 |
Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Annals of Surgery. 253: 572-9. PMID 21209588 DOI: 10.1097/Sla.0B013E318208Fc2A |
0.631 |
|
| 2011 |
Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. 117: 916-24. PMID 20945319 DOI: 10.1002/Cncr.25505 |
0.408 |
|
| 2011 |
Gainer S, Mittendorf E, Hunt K, Bassett R, Yi M, Meric-Bernstam F, Ross M, Babiera G, Kuerer H, Caudle A, Hwang R. P3-07-05: Nomogram Incorporating SLN Metastasis Size Provides the Most Accurate Prediction of Non-SLN Involvement in Breast Cancer Patients. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P3-07-05 |
0.516 |
|
| 2010 |
Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clinical Breast Cancer. 10: 477-82. PMID 21147692 DOI: 10.3816/Cbc.2010.N.063 |
0.477 |
|
| 2010 |
Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Annals of Surgical Oncology. 17: 343-51. PMID 20853057 DOI: 10.1245/S10434-010-1253-3 |
0.424 |
|
| 2010 |
Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer? Annals of Surgical Oncology. 17: 280-5. PMID 20853047 DOI: 10.1245/S10434-010-1235-5 |
0.421 |
|
| 2010 |
Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prevention Research (Philadelphia, Pa.). 3: 1026-34. PMID 20647335 DOI: 10.1158/1940-6207.Capr-09-0130 |
0.564 |
|
| 2010 |
Mittendorf E, Boughey J, Degnim A, Harrell R, Bassett R, Yi M, Meric-Bernstam F, Ross M, Babiera G, Kuerer H, Lucci A, Bedrosian I, Hunt K, Hwang R. Abstract PD06-08: Size Matters: Incorporation of Sentinel Lymph Node (SLN) Metastasis Size into a Nomogram Predicting NonSLN Involvement in SLN Positive Breast Cancer Patients Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd06-08 |
0.478 |
|
| 2010 |
Yi M, Kuerer H, Lucci A, Meric-Bernstam F, Babiera G, Thomas C, Ross M, Hunt K. Abstract P4-10-14: Risk of Ipsilateral Breast Events in Patients with Ductal Carcinoma In Situ after Local Excision Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-10-14 |
0.517 |
|
| 2009 |
Yi M, Hunt KK, Arun BK, Bedrosian I, Gutierrez Barrera AM, Kuerer HM, Babiera G, Mittendorf EA, Meric-Bernstam F. Factors leading to the decision for contralateral prophylactic mastectomy in patients with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1528. PMID 27964347 DOI: 10.1200/Jco.2009.27.15_Suppl.1528 |
0.541 |
|
| 2009 |
Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Annals of Surgery. 250: 558-66. PMID 19730235 DOI: 10.1097/Sla.0B013E3181B8Fd5E |
0.499 |
|
| 2009 |
Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 115: 962-71. PMID 19172584 DOI: 10.1002/Cncr.24129 |
0.567 |
|
| 2009 |
Yi M, Hunt K, Meric-Bernstam F, Kronowitz S, Nayeemuddin K, Feig B, Hwang R, Symmans W, Lucci A, Ross M, Ames F, Bedrosian I, Singletary E, Kuerer H. Local-regional and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Cancer Research. 69: 4138. DOI: 10.1158/0008-5472.Sabcs-4138 |
0.527 |
|
| 2008 |
Kong AL, Hunt KK, Yi M, Weatherspoon K, Bedrosian I, Tereffe W, Hwang R, Ross MI, Buchholz TA, Meric-Bernstam F. The impact of IMC nodal drainage on primary breast cancer outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 534. PMID 27948395 DOI: 10.1200/Jco.2008.26.15_Suppl.534 |
0.531 |
|
| 2008 |
Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Annals of Surgical Oncology. 15: 3369-77. PMID 18815841 DOI: 10.1245/S10434-008-0153-2 |
0.445 |
|
| 2008 |
Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 113: 30-37. PMID 18457326 DOI: 10.1002/Cncr.23514 |
0.485 |
|
| 2008 |
Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KK. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer. 112: 2646-54. PMID 18442039 DOI: 10.1002/Cncr.23481 |
0.396 |
|
| 2008 |
Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. American Journal of Surgery. 196: 81-7. PMID 18436181 DOI: 10.1016/J.Amjsurg.2007.08.057 |
0.528 |
|
| 2007 |
Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 110: 723-30. PMID 17587208 DOI: 10.1002/Cncr.22847 |
0.517 |
|
| 2007 |
Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 110: 731-7. PMID 17582626 DOI: 10.1002/Cncr.22835 |
0.505 |
|
| 2006 |
Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. American Journal of Surgery. 192: 552-5. PMID 16978974 DOI: 10.1016/J.Amjsurg.2006.06.020 |
0.495 |
|
| 2006 |
Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. Journal of the American College of Surgeons. 203: 64-72. PMID 16798488 DOI: 10.1016/J.Jamcollsurg.2006.03.015 |
0.499 |
|
| 2006 |
Jeruss JS, Ayers GD, Cristofanilli M, Ross MI, Babiera G, Meric-Bernstam F, Kuerer HM, Feig BW, Yi M, Hunt KK. Postive sentinel nodes after neoadjuvant chemotherapy: What factors predict additional disease in the axilla? Journal of Clinical Oncology. 24: 602-602. DOI: 10.1200/Jco.2006.24.18_Suppl.602 |
0.405 |
|
| 2005 |
Khakpour N, Lucci A, Yi M, Meric-Bernstam F, Kuerer HM, Babiera GV, Ross MI, Buchholz T, Garg A, Hunt KK. Sentinel lymph node dissection provides similar local-regional control compared to axillary dissection in patients with node negative breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 588. PMID 27946248 DOI: 10.1200/Jco.2005.23.16_Suppl.588 |
0.479 |
|
| 2005 |
Fang JC, Wu ZW, Liu XS, Yi MY, Luo SY, Zeng LS, Zhao ZY, Li YY, Peng XP, Yao XM, Zhou YC, Pi H. [Study on the strategy of interrupting schistosomiasis transmission in a hilly new endemic area of Taoyuan County]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases. 23: 300-3. PMID 16562483 |
0.38 |
|
| 2005 |
Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci A. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. American Journal of Surgery. 190: 598-601. PMID 16164930 DOI: 10.1016/J.Amjsurg.2005.06.021 |
0.479 |
|
| Show low-probability matches. |